Hemorrhagic Kaposi sarcoma. Successful treatment with IFN-α

European Journal of Dermatology

Volumn 14, Issue 1, 2004, Pages 37-40

  Bassioukas, Konstantinos ^a   Zioga, Aikaterini ^b   Hantschke, Markus ^c   Klouvas, George ^b   Hatzis, John ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^c Dermatopathologische Gemeinschaftspraxis   (Germany)

Author keywords

Interferon alpha 2b; Kaposi (lymphangioma like) sarcoma

Indexed keywords

CORTICOSTEROID; EMOLLIENT AGENT; RECOMBINANT ALPHA2B INTERFERON;

AGED; ARTICLE; CANCER RECURRENCE; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; FEMALE; FLU LIKE SYNDROME; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; IMMUNOTHERAPY; KAPOSI SARCOMA; MAINTENANCE THERAPY; MEDICAL EXAMINATION; TREATMENT OUTCOME; TUMOR BLEEDING;

AGED; BIOPSY, NEEDLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; INTERFERON ALFA-2B; RISK ASSESSMENT; SARCOMA, KAPOSI; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0442313534     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kaloterakis A, Stratigos J, Filiotou A, Kaloterakis M, Hatzakis A, Hadjiyiannis St. Mediterranean Kaposi's sarcoma: Risk factors. Hellen Dermatol Venereol Rev 1995; 6(2): 96-106.
2. Moore PS, Chang Y. Detection of herpes virus-like sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995; 332: 1181-5.
3. Kemeni L, Gyulai R, Kiss M, Nagy F, Dobozy A. Kaposi's sarcoma associated herpesvirus/human herpesvirus 8: A new virus in human pathology. J Am Acad Dermatol 1997; 37: 107-13.
4. Blumenfeld W, Egbert BM, Sagebiel RW. Differential diagnosis of Kaposi's sarcoma. Arch Pathol Lab Med 1985; 109: 123-7.
5. Schartz RA, Spicer MS, Thomas I, Janniger CK, Clark Lambert W. Ecchymotic Koposi's Sarcomo. Cutis 1995; 56: 104-6.
6. Gange RW, Wilson-Jones E. Lymphongioma like Kaposi's Sorcoma. A report of three cases. Br J Dermatol 1979; 100: 327-34.
7. Pietter WW. The incidence of second malignancies in subsets of Kaposi's sarcoma. J Am Acad Dermatol 1987; 16: 855-61.
8. Rashkovsky I, Gilead L, Schamroth J, Leibovici V. Acroangiodermatitis: Review of the literature and report of a case. Acta Derm Venereol (Stockh.) 1995; 75: 475-8.
9. Goldblum OM, Kraus E, Bronner AK. Pseudo-Kaposi's sarcoma of the hand associated with an acquired iatrogenic arteriovenous fistula. Arch Dermatol 1985; 121: 1038-40.
10. Koppel RA, Marrogi AJ, Fishman SJ. Unilateral pseudo-Kaposi's sarcoma (Bluefarb-Stewort type). Cutis 1994; 54: 257-60.
11. th Edition, Blackwell Scientific Publications, 1992: 2073-92.
12. Zhu W-Y, Penneys NS, Reyes B, Khatib Z and Schachner L. Acquired progressive lymphangioma. J Am Acad Dermatol 1991; 24(5): 813-5.
13. Mehregan DR, Mehregan AH, Mehregan DA. Benign lymphangioendothelioma: report of 2 cases. J Cutan Pathol 1992; 19: 502-5.
14. Scott Herron G, Rouse RV, Kosek JC, Smoller BR and Egbert BM. Benign lymphangioendothelioma. J Am Acad Dermatol 1994; 31: 362-8.
15. Reed CN, Cooper RH, Swerlick RA. Intravascular papillary endothelial hyperplasia (multiple lesions simulating Kaposi's sarcoma). J Am Acad Dermatol 1984; 10: 110-3.
16. Galdstein JB, Scott McNutt N, Hambrick GW Jr, Hsu A. Penicillamine dermatopathy with lymphangiectases. A clinical, immunohistologic and ultrastructural study. Arch Dermatol 1989; 125: 92-7.
17. Santa Cruz DJ, Aronberg J. Targetoid hemosiderotic hemangioma. J Am Acad Dermatol 1988; 19: 550-8.
18. Adler MJ, Beckstead J, White CR. Angiomatoid Melanoma: A case of metastatic melanoma mimicking a vascular malignancy. Am J Dermatopathol 1997; 19: 606-9.
19. Ronchese D, Kern AB. Lymphangiona-like tumors in Kaposi's sarcoma. AMA Arch Dermatol 1957; 75: 418-27.
20. Masia IM, Mugoni MG, Massarevlli G, Rovasio S, Cottoni G. Lymphangioma like pattern and anaplastic evolution in a case of classic Kaposi's sarcoma. J Eur Acad Dermatol Venereol 1997; 9: 181-4.
21. Rubegni P, Cuccia A, Sbano B, Miracco C, Pacenti L, Fimiani M. Disseminated Mediterranean Kaposi Sarcoma treated with low-dose recombinant interferon-alpha-2a J Am Acad Dermatol 2003; 48: 148-9.
22. Tsampaos D, Georgiou S, Kapranos N, Georgala S, Zografaki Ch, Stratigos A, Koutselini H and Berger H. Systemische therapie des klassischen Kaposi-Sarcomes mit Interferon alpha-2b. H + G 1994; 69(11): 754-8.
23. Costa da Cunha CS, Lebbe C, Rybojad M, Ferchal F, Rabian C, Vignon-Pennamen MD, Calvo F, Morel P. Long term follow-up of non-HIV Kaposi's sarcomo treated with low-dose recombinant interferon-alpha 2b. Arch Dermatol 1996; 132: 285-90.
24. Somos S, Farkas B. Immunomodulatory treatment with low-dose interferon-alpha and oral retinoic acid in lymphangioma-like Kaposi's sarcoma. Anticancer Res 2000; 20: 541-5.
25. Kirkwood J. Cancer immunotherapy: the interferon-alpha experience. Semin Oncol 2002; 29 (Suppl.7): 18-26.
26. Deihmann M, Thome M, Jackel A, Utermann S, Bock M, Walmann V, Naher H. Non-human immunodeficiency virus Kaposi's sarcoma can be effectively treated with low-dose interferon-alpha despite the persistence of herpes virus-8. Br J Dermatol, 1998; 139: 1052-4.
27. Pfrommer C, Tebbe B, Tidona CA, Wolfer U, Krengel S, Zeichardt H, Zouboulis CC, Orfanos CE. Progressive HHV-8-positive classic Kaposi's sarcoma: rapid response to interferon alpha-2a but persistence of HHV-8 DNA sequences in lesional skin. Br J Dermatol, 1998; 139: 516-9.